Skip to main content

RETRACTION article

Front. Oncol., 25 May 2023
Sec. Radiation Oncology
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1205993

Retraction: Akt inhibition enhanced the growth inhibition effect of low-dose heavy-ion radiation via the PI3K/Akt/P53 signaling pathway in C6 glioblastoma cells

This article is a retraction of:

  1. RETRACTED: Akt Inhibition Enhanced the Growth Inhibition Effects of Low-Dose Heavy-Ion Radiation via the PI3K/Akt/p53 Signaling Pathway in C6 Glioblastoma Cells

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    A Retraction of the Original Research Article
    Akt inhibition enhanced the growth inhibition effects of low-dose heavy-ion radiation via the PI3K/Akt/p53 signaling pathway in C6 glioblastoma cells

    by Huang K, Zhao W, Wang X, Qiu Y, Liu Z, Chen R, Liu W and Liu B (2021) Front. Oncol. 11:649176. doi: 10.3389/fonc.2021.649176

    The journal retracts the April 1, 2021 article cited above.

    Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

    This retraction was approved by the Chief Editors of Frontiers in Oncology.

    The authors did not agree to this retraction.

    Citation: Frontiers Editorial Office (2023) Retraction: Akt inhibition enhanced the growth inhibition effect of low-dose heavy-ion radiation via the PI3K/Akt/P53 signaling pathway in C6 glioblastoma cells. Front. Oncol. 13:1205993. doi: 10.3389/fonc.2023.1205993

    Received: 14 April 2023; Accepted: 20 April 2023;
    Published: 25 May 2023.

    Approved by:

    Timothy James Kinsella, Brown University, United States

    Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.